Thermo Fisher Scientific talks qPCR, digital PCR, NGS for infectious diseases at AMP 2022

Leo O'Connor
Nov 17, 2022
Latest in Business Insights
Legal Scales Social
Bio-Techne files patent infringement suit against Molecular Instruments
April 23, 2024
Business Graph Money Stocks
Fujifilm Diosynth Biotechnologies confirms layoffs
April 19, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Stock Exchange Social
DermTech receives delisting warning from Nasdaq
April 17, 2024
Related Stories
Hands Shaking Deal
Mergers & Acquisitions
Thermo Fisher Scientific, Heska complete previously announced acquisitions
3 D Monkeypox Infecting Cell Social
PCR
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
Sequencing Dna Rna Social
Cancer
AMP assesses clinical implementation of past standards, guidelines for sequence variants in cancer
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Business Insights
Bio-Techne files patent infringement suit against Molecular Instruments
By LabPulse.com staff writers
Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.
April 23, 2024
Legal Scales Social
Fujifilm Diosynth Biotechnologies confirms layoffs
By LabPulse.com staff writers
Fujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.
April 19, 2024
Business Graph Money Stocks
Bruker to acquire NanoString for $392.6M
By LabPulse.com staff writers
NanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.
April 18, 2024
Business Handshake Man Social
DermTech receives delisting warning from Nasdaq
By LabPulse.com staff writers
Melanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.
April 17, 2024
Stock Exchange Social
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
By LabPulse.com staff writers
Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.
April 17, 2024
Blood Test Samples Lab Social
Co-Diagnostics opens manufacturing facility in Utah
By LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.
April 16, 2024
Lab Vacutainer Test Tube Social
OraSure discloses cybersecurity breach
By LabPulse.com staff writers
OraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.
April 15, 2024
Cybersecurity Locks Social
Roche, Lilly Alzheimer's blood test granted FDA breakthrough device designation
By LabPulse.com staff writers
The Alzheimer's blood test developed through a collaboration between Roche and Lilly has been granted a breakthrough device designation by the U.S. Food and Drug Administration (FDA).
April 11, 2024
Alzheimers Tau Tangles Social
European Commission approves Illumina's plan to divest Grail
By LabPulse.com staff writers
The European Commission has approved Illumina's plan to divest multicancer early detection test maker Grail under the European Union Merger Regulation adopted by the EC in October 2023.
April 12, 2024
Eu Flag European Commission Brussels Social
Roche's breast cancer CDx receives CE Mark
By LabPulse.com staff writers
Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.
April 10, 2024
Breast Mammo Social
Seaport Therapeutics launches with $100M financing round
By LabPulse.com staff writers
Clinical-stage biopharmaceutical company Seaport Therapeutics launched with the announcement of the closing of a $100 million oversubscribed series A financing round.
April 9, 2024
Research Money Social
Johnson & Johnson to acquire Shockwave Medical
By LabPulse.com staff writers
Johnson & Johnson will acquire Shockwave Medical, expanding Johnson & Johnson MedTech's position in the growing medtech market for cardiovascular intervention.
April 8, 2024
Heart Artificial Intelligence Ai Social
Page 1 of 177
Next Page